Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases
US7897579B2 · kind B2 · utility
10Cited by
4References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2005 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Apr 29, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/75
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a compound comprising D-mannoheptulose and/or perseitol for producing a drug for treating and/or preventing diseases related to the modification of an innate and/or acquired immunity by increasing the production of antimicrobial peptides, preferably hBD-2 without inducing inflammatory reactions, irritation or intolerance. Said compound can also comprise a peptidic avocado extract and/or a peptidic lupin extract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.